Skip to main content
Jeffery Taubenberger, MD, Pathology, Bethesda, MD

JefferyKTaubenbergerMDPhD

Pathology • Bethesda, MD

Microbiology, Molecular Genetics, Anatomic Pathology, Surgical Pathology

Chief, Viral Pathogenesis and Evolution Section, NIAID, NIH

Join to view full profile

Dr. Taubenberger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Taubenberger's full profile

Already have an account?

  • Office

    33 North Drive, MSC 3203
    NIAID, NIH
    Bethesda, MD 20892
    Phone+1 301-761-6453
    Fax+1 301-480-1696

Education & Training

  • Virginia Commonwealth University
    Virginia Commonwealth UniversityPh.D., Anatomy, 1982 - 1987
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1986
  • George Mason University
    George Mason UniversityBS, Biology, 1979 - 1982

Certifications & Licensure

  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Molecular Genetic Pathology

Awards, Honors, & Recognition

  • Elected Member Association of American Physicians
  • Elected Member American Academy of Microbiology
  • 2008 University Alumnus of the Year George Mason University, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses  
    Jeffery Taubenberger, MD, mBio

Press Mentions

  • American Institute to Test Universal Flu Vaccine
    American Institute to Test Universal Flu VaccineJuly 12th, 2022
  • Here We Go: NIH Begins Testing Phase I Clinical Trial of Universal Flu Vaccine
    Here We Go: NIH Begins Testing Phase I Clinical Trial of Universal Flu VaccineJuly 1st, 2022
  • Universal Influenza Vaccine, Developed at NIAID, Starts Clinical Trial
    Universal Influenza Vaccine, Developed at NIAID, Starts Clinical TrialJune 29th, 2022
  • Join now to see all

Grant Support

  • H1N1 Influenza Comparative PathogenesisNational Institute Of Allergy And Infectious Diseases2011
  • H1N1 Influenza Clinical ResearchNational Institute Of Allergy And Infectious Diseases2011
  • Influenza Viral PathogenesisNational Institute Of Allergy And Infectious Diseases2009–2011
  • Influenza Viral Genomics And EvolutionNational Institute Of Allergy And Infectious Diseases2009–2011
  • Analysis Of Historical Influenza VirusesNational Institute Of Allergy And Infectious Diseases2009–2011
  • Arra [Unreadable]H1n1 Influenza Clinical ResearchNational Institute Of Allergy And Infectious Diseases2009–2010
  • Arra [Unreadable] H1N1 Influenza Comparative PathogenesisNational Institute Of Allergy And Infectious Diseases2009–2010
  • Influenza Viral PathogenesisNational Institute Of Allergy And Infectious Diseases2007–2008
  • Influenza Viral Genomics And EvolutionNational Institute Of Allergy And Infectious Diseases2007–2008
  • Analysis Of Historical Influenza VirusesNational Institute Of Allergy And Infectious Diseases2007–2008
  • Viral And Host CDNA Libraries From 1918 Influenza CasesNational Institute Of Allergy And Infectious Diseases2004–2008
  • Complete Characterization Of The 1918 Influenza VirusNational Institute Of Allergy And Infectious Diseases2002–2006
  • Thymic Epithelial Cell Induced Prothymocyte MigrationNational Institute On Aging1986

Other Languages

  • German

Dr. Jeffery Taubenberger, Dr. Jeffery Taubenberger, MD, Dr. J Taubenberger, Dr. Jeffery K Taubenberger